Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
contract manufacturing
Pharma
WuXi Bio continues to snag new projects despite BIOSECURE fears
Despite some drugmakers’ recent concerns around working with Chinese manufacturers, WuXi Bio continues to pick up a steady stream of new contracts.
Fraiser Kansteiner
Aug 22, 2024 9:58am
Merck KGaA, analysts share optimism about potential CDMO rebound
Aug 7, 2024 3:13pm
CDMO Rentschler's new MA production line is up and running
Jul 12, 2024 9:34am
Samsung Bio inks $1B production pact with unnamed US pharma
Jul 2, 2024 1:55pm
Lupin names CEO for its newly announced CDMO arm
Jun 17, 2024 2:54pm
New bill sets decoupling deadline for industry's work with WuXi
May 10, 2024 11:30am
